> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Vote on Non-RX Birth Control Pill
- URL: https://www.fdaweb.com/panel-to-vote-on-non-rx-birth-control-pill/
- Published: 2023-03-30T12:00:00.000Z
- Updated: 2026-09-14T18:22:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154107

*Federal Register* notice: FDA has announced a 5/9 joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee. Panel members are scheduled to discuss a Laboratoire HRA Pharma supplemental NDA for Opill (norgestrel), indicated for nonprescription use as a once-daily oral contraceptive. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-03-29/pdf/2023-06524.pdf?ref=fdaweb.com).